ARCHIVES

Board Defers core Guideline changes, Asks Subcommittee For Alternate Plans

This article is from The Cancer Letter archive.

Vol. 03 No. 46 | November 18, 1977

Download PDF Visit The Full Archive

Related Articles

FDA Approves Rituxan For NHL With CHOP Therapy

February 24, 2006

ColoPrint Improves Prognosis In Stage II and III Colon Cancer

January 28, 2011

Cancer Cases To Double By 2050, Annual Report Says

May 31, 2002

Meta-Analysis Of Randomized Trials Shows Aspirin Reduces Colon Polyp Recurrence

February 27, 2009

NCI’s SBIR Awards Move Up In Quality; Congress considers Making It Permanent; FASEB Object

September 19, 1986

Senators Tie Medicare Oral Drug Payment to Ending Markup on Infused Drugs

March 22, 2002